Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Select Advanced Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00939666
What this trial is testing

Minimal Invasive Strategies for Good and Complete Response to Chemoradiation in Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Maastricht University Medical Center 28
Early research (Phase 1)Study completedNCT00848718
What this trial is testing

A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003)

Who this might be right for
Locally Advanced, Metastatic Solid Tumors
Merck Sharp & Dohme LLC 77
Testing effectiveness (Phase 2)Study completedNCT00818441
What this trial is testing

Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

Who this might be right for
Carcinoma, Non-small Cell
Pfizer 119
Not applicableLooking for participantsNCT05524090
What this trial is testing

PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic AdenocarcinomaPancreatic Adenocarcinoma Non-resectable+1 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 223
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more
National Cancer Institute (NCI) 1,377
Not applicableUnknownNCT04790227
What this trial is testing

MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer

Who this might be right for
Cancer, Rectum
Assiut University 50
Early research (Phase 1)Ended earlyNCT04294160
What this trial is testing

Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

Who this might be right for
BRAF V600 Colorectal Cancer
Novartis Pharmaceuticals 122
Testing effectiveness (Phase 2)Looking for participantsNCT06975293
What this trial is testing

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Who this might be right for
Solid TumorSarcomaLeiomyosarcoma+1 more
STORM Therapeutics LTD 107
Testing effectiveness (Phase 2)Ended earlyNCT05715229
What this trial is testing

Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hackensack Meridian Health 5
Large-scale testing (Phase 3)Looking for participantsNCT07708753
What this trial is testing

SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers

Who this might be right for
Platinum-resistant Ovarian CancerPlatinum-resistant Primary Peritoneal CancerPlatinum-resistant Fallopian Tube Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd. 460
Early research (Phase 1)Study completedNCT03525795
What this trial is testing

ORIOn-E: A Study Evaluating CPI-1205 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Constellation Pharmaceuticals 24
Early research (Phase 1)Study completedNCT02937116
What this trial is testing

First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors

Who this might be right for
Cancer, Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd. 233
Early research (Phase 1)Ended earlyNCT02437916
What this trial is testing

Safety Study of AMG 228 to Treat Solid Tumors

Who this might be right for
Advanced MalignancyAdvanced Solid TumorsCancer+8 more
Amgen 30
Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Early research (Phase 1)Ended earlyNCT04613492
What this trial is testing

MEDI9253 in Combination With Durvalumab in Select Solid Tumors

Who this might be right for
Solid Tumors
AstraZeneca 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06519370
What this trial is testing

FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT04015622
What this trial is testing

PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
British Columbia Cancer Agency 100
Not applicableNot Yet RecruitingNCT07819474
What this trial is testing

Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With

Who this might be right for
Tumor Infiltrating LymphocyteCD8-PETAdvanced Melanoma
M.D. Anderson Cancer Center 6
Large-scale testing (Phase 3)Study completedNCT01404260
What this trial is testing

Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials 219
Large-scale testing (Phase 3)Looking for participantsNCT07265674
What this trial is testing

Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract CancerBiliary Tract Cancer (BTC)
J-Pharma Co., Ltd. 480
Next Page